Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

4.76USD
10 Dec 2018
Change (% chg)

$0.01 (+0.21%)
Prev Close
$4.75
Open
$4.78
Day's High
$4.86
Day's Low
$4.61
Volume
76,200
Avg. Vol
405,287
52-wk High
$10.38
52-wk Low
$1.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.05 -0.502
Jun '18 0.84 -0.430
Mar '18 0.94 -0.320
FY 2017 Dec '17 1.62 -0.507
Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 1.11 1.40 0.95 --
Quarter Ending Mar-19 3 0.95 1.10 0.80 --
Year Ending Dec-18 4 3.95 4.24 3.79 2.46
Year Ending Dec-19 4 4.06 4.45 3.50 2.14
Earnings (per share)
Quarter Ending Dec-18 4 -0.43 -0.38 -0.51 -0.72
Quarter Ending Mar-19 3 -0.46 -0.38 -0.54 --
Year Ending Dec-18 4 -1.67 -1.62 -1.78 -2.35
Year Ending Dec-19 4 -1.79 -1.16 -2.35 -2.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) 6.98 116.41 5.77
Price to Book (MRQ) 1.08 15.60 5.12
Price to Tangible Book (MRQ) 1.08 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 74.37 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -20.95 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago 57.47 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -43.17 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 2.39 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 5.65 5.42 3.11
LT Debt to Equity (MRQ) 0.00 33.58 11.47
Total Debt to Equity (MRQ) 0.00 35.41 15.63
Interest Coverage (TTM) -177.45 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -660.33 -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -664.11 -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -657.71 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -657.71 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 111,873 25,687,363 898,926,015
Net Income/Employee (TTM) -735,803 2,194,067 106,550,787
Receivable Turnover (TTM) 18.26 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.15 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.82 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -123.49 0.28 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -127.78 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % 94.43 94.41 --
EPS (TTM) % -68.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -3.45 39 57
13 Week -53.57 -55.83 3 62
26 Week -69.00 -71.36 4 81
52 Week -85.16 -87.42 3 47
YTD -81.97 -84.17 1 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.71%
# of Holders: 83
Total Shares Held: 27,877,296
3 Mo. Net Change: 3,916,274
# New Positions: 13
# Closed Positions: 14
# Increased Positions: 39
# Reduced Positions: 31
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.